Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06011109
Title Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Aveta Biomics, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.